Solutions for Hemodialysis Vascular access Dysfunction: Thinking out of the Box!!

Fitzgerald J.T. , Schanzer A. , Chin A.I. , McVicar J.P. , Perez R.V. , Troppmann C. . Outcomes of upper arm arteriovenous fistulas for maintenance hemodialysis access. Arch Surg 2004; 139(2): 201–8.

Tordoir J.H. , Rooyens P. , Dammers R. , van der Sande F.M. , de Haan M. , Yo T.I. . Prospective evaluation of failure modes in autogenous radiocephalic wrist access for haemodialysis. Nephrol Dial Transplant 2003; 18(2): 378–83.

Schwab S.J. , Harrington J.T. , Singh A. Vascular access for hemodialysis [clinical conference]. Kidney Int 1999; 55(5): 2078–90.

Malovrh M. . Native arteriovenous fistula: preoperative evaluation. Am J Kidney Dis 2002; 39(6): 1218–25.

Patel S.T. , Hughes J. , Mills J.L. Sr . Failure of arteriovenous fistula maturation: an unintended consequence of exceeding dialysis outcome quality Initiative guidelines for hemodialysis access. J Vasc Surg 2003; 38(3): 439–45; discussion 45.

Roy-Chaudhury P. , Kelly B.S. , Zhang J. Hemodialysis vascular access dysfunction: from pathophysiology to novel therapies. Blood Purif 2003; 21(1): 99–110.

Shi Y. , O'Brien J.E. , Fard A. , Mannion J.D. , Wang D. , Zalewski A. . Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 1996; 94(7): 1655–64.

Sata M. , Saiura A. , Kunisato A. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8(4): 403–9.

Rekhter M. , Nicholls S. , Ferguson M. , Gordon D. . Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscler Thromb 1993; 13(4): 609–17.

Swedberg S.H. , Brown B.G. , Sigley R. , Wight T.N. , Gordon D. , Nicholls S.C. . Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment. Circulation 1989; 80(6): 1726–36.

Roy-Chaudhury P. , Kelly B.S. , Miller M.A. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int 2001; 59(6): 2325–34.

Schwartz R.S. , Topol E.J. , Serruys P.W. , Sangiorgi G. , Holmes D.R. Jr. . Artery size, neointima, and remodeling: time for some standards. J Am Coll Cardiol 1998; 32(7): 2087–94.

Ravani P. , Brunori G. , Mandolfo S. Cardiovascular comorbidity and late referral impact arteriovenous fistula survival: a prospective multicenter study. J Am Soc Nephrol 2004; 15(1): 204–9.

Lee T. , Barker J. , Allon M. . Associations with predialysis vascular access management. Am J Kidney Dis 2004; 43(6): 1008–13.

Miller C.D. , Robbin M.L. , Allon M. . Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. Kidney Int 2003; 63(1): 346–52.

Feldman H.I. , Joffe M. , Rosas S.E. , Burns J.E. , Knauss J. , Brayman K. . Predictors of successful arteriovenous fistula maturation. Am J Kidney Dis 2003; 42(5): 1000–12.

Faiyaz R. , Abreo K. , Zaman F. , Pervez A. , Zibari G. , Work J. . Salvage of poorly developed arteriovenous fistulae with percutaneous ligation of accessory veins. Am J Kidney Dis 2002; 39(4): 824–7.

Dinwiddie L.C. . Interventions to promote fistula maturation. Nephrol Nurs J 2002; 29(4): 377, 402.

Allon M. , Robbin M.L. . Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int 2002; 62(4): 1109–24.

Sands J. , Miranda C.L. . Increasing numbers of AV fistulas for hemodialysis access. Clin Nephrol 1997; 48(2): 114–7.

Nugent H.M. , Groothuis A. , Seifert P. Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: a safety and efficacy study in the pig. J Vasc Res 2002; 39(6): 524–33.

Hoffer E.K. , Sultan S. , Herskowitz M.M. , Daniels I.D. , Sclafani S.J. . Prospective randomized trial of a metallic intravascular stent in hemodialysis graft maintenance. J Vasc Interv Radiol 1997; 8(6): 965–73.

Beathard G.A. . The use of the Gianturco intravascular stent in stenotic hemodialysis fistulas. ASAIO Trans 1991; 37(3): M234–5.

Morice M.C. , Serruys P.W. , Sousa J.E. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346(23): 1773–80.

Stone G.W. , Ellis S.G. , Cox D.A. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350(3): 221–31.

REALITY: Prospective, Randomized, Multicenter Head-to-Head Comparison of Cypher and Taxus Stent Systems. Medscape Internal Medicine, 2005. (Accessed April 16th, 2005, at http://www.med-scape.com/viewarticle/501393.)

Rotmans J.I. , Pattynama P.M. , Verhagen H.J. Sirolimus-eluting stents to abolish intimal hyperplasia and improve flow in porcine arteriovenous grafts: a 4-week follow-up study. Circulation 2005; 111(12): 1537–42.

Haskal. Stent Grafts. In: Society of Interventional Radiology; 2005; New Orleans; 2005.

Brauner R. , Laks H. , Drinkwater D.C. Jr. Controlled periadventitial administration of verapamil inhibits neointimal smooth muscle cell proliferation and ameliorates vasomotor abnormalities in experimental vein bypass grafts. J Thorac Cardiovasc Surg 1997; 114(1): 53–63.

Teomim D. , Fishbien I. , Golomb G. , Orloff L. , Mayberg M. , Domb A.J. . Perivascular delivery of heparin for the reduction of smooth muscle cell proliferation after endothelial injury. J Controlled Release 1999; 60(1): 129–42.

Villa A.E. , Guzman L.A. , Chen W. , Golomb G. , Levy R.J. , Topol E.J. . Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. J Clin Invest 1994; 93(3): 1243–9.

Chaux A. , Ruan X.M. , Fishbein M.C. Perivascular delivery of a nitric oxide donor inhibits neointimal hyperplasia in vein grafts implanted in the arterial circulation. J Thorac Cardiovasc Surg 1998; 115(3): 604–12; discussion 12–4.

Edelman E.R. , Nugent M.A. , Karnovsky M.J. . Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition. Proc Natl Acad Sci USA 1993; 90(4): 1513–7.

Kaul S. , Cercek B. , Rengstrom J. Polymeric-based perivascular delivery of a nitric oxide donor inhibits intimal thickening after balloon denudation arterial injury: role of nuclear factor-kappaB. J Am Coll Cardiol 2000; 35(2): 493–501.

Laham R.J. , Sellke F.W. , Edelman E.R. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 1999; 100(18): 1865–71.

Lopez J.J. , Edelman E.R. , Stamler A. , Morgan J.P. , Sellke F.W. , Simons M. . Local perivascular administration of basic fibroblast growth factor: drug delivery and toxicological evaluation [published erratum appears in Drug Metab Dispos 1996; 24 (10): 1166]. Drug Metab Dispos 1996; 24(8): 922–4.

Golomb G. , Fishbein I. , Banai S. Controlled delivery of a tyrphostin inhibits intimal hyperplasia in a rat carotid artery injury model. Atherosclerosis 1996; 125(2): 171–82.

Kelly B. , Melhem M. , Desai P. , Kasting G. , Zhang J. , Li J. , Heffelfinger S. , Rudich S. , Roy-Chaudhury P. . Perivascular Paclitaxel Polymers Reduce Neointimal Hyper-plasia and Venous Stenosis in PTFE Arteriovenous Grafts: A Solution for Hemodialysis Vascular Access Dysfunction? J Am Soc Nephrol (ASN 2004 abstract).

Masaki T. , Rathi R. , Zentner G. Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel. Kidney Int 2004; 66(5): 2061–9.

Tanaka K. , Sata M. , Hirata Y. , Nagai R. . Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res 2003; 93(8): 783–90.

Fukuda D. , Sata M. , Tanaka K. , Nagai R. . Potent inhibitory effect of sirolimus on circulating vascular progenitor cells. Circulation 2005; 111(7): 926–31.

Urbich C. , Dimmeler S. . Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004; 95(4): 343–53.

Werner N. , Junk S. , Laufs U. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003; 93(2): e17–24.

Griese D.P. , Ehsan A. , Melo L.G. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 2003; 108(21): 2710–5.

Szmitko P.E. , Fedak P.W. , Weisel R.D. , Stewart D.J. , Kutryk M.J. , Verma S. . Endothelial progenitor cells: new hope for a broken heart. Circulation 2003; 107(24): 3093–100.

Kong D. , Melo L.G. , Gnecchi M. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004; 110(14): 2039–46.

Bhattacharya V. , McSweeney P.A. , Shi Q. Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells. Blood 2000; 95(2): 581–5.

He H. , Shirota T. , Yasui H. , Matsuda T. . Canine endothelial progenitor cell-lined hybrid vascular graft with nonthrombogenic potential. J Thorac Cardiovasc Surg 2003; 126(2): 455–64.

Shirota T. , Yasui H. , Shimokawa H. , Matsuda T. . Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials 2003; 24(13): 2295–302.

Ong A.T. , Aoki J. , Kutryk M.J. , Serruys P.W. . How to accelerate the endothelialization of stents. Arch Mal Coeur Vaiss 2005; 98(2): 123–6.

Frost M.C. , Reynolds M.M. , Meyerhoff M.E. . Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contacting medical devices. Biomaterials 2005; 26(14): 1685–93.